These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 1905431)

  • 21. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacodynamics and pharmacokinetics of flecainide in cardiac pre-excitation of the bundle of Kent].
    Casiglia E; Padrini R; Piovan D; Marchese D; Sforza G; Martines C; Pessina AC
    Cardiologia; 1989 May; 34(5):425-9. PubMed ID: 2503250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
    G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and electrocardiographic effects of a new controlled-release form of flecainide acetate: comparison with the standard form and influence of the CYP2D6 polymorphism.
    Tennezé L; Tarral E; Ducloux N; Funck-Brentano C
    Clin Pharmacol Ther; 2002 Aug; 72(2):112-22. PubMed ID: 12189358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-threatening flecainide intoxication in a young child secondary to medication error.
    D'Alessandro LC; Rieder MJ; Gloor J; Freeman D; Buffo-Sequiera I
    Ann Pharmacother; 2009 Sep; 43(9):1522-7. PubMed ID: 19671803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring: antiarrhythmic drugs.
    Campbell TJ; Williams KM
    Br J Clin Pharmacol; 1998 Oct; 46(4):307-19. PubMed ID: 9803978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide: what are we measuring?
    Ray J
    Ther Drug Monit; 1990 Jul; 12(4):416. PubMed ID: 2118694
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of flecainide concentration in blood plasma by HPLC and pharmacokinetic parameters in volunteers].
    Li XY; He JB; Tan WP; Yu ST; Huang W; Sun JP; Yu CH; Qian F
    Yao Xue Xue Bao; 1989; 24(6):452-7. PubMed ID: 2514579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of flecainide and lorcainide in blood by means of TLC.
    Paw B; Przyborowski L
    Acta Pol Pharm; 1995; 52(1):5-7. PubMed ID: 8960234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibition of flecainide resorption by activated charcoal].
    Nitsch J; Köhler U; Lüderitz B
    Z Kardiol; 1987 May; 76(5):289-91. PubMed ID: 3113085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flecainide: what are we measuring?
    Watson ID
    Ther Drug Monit; 1991 Jan; 13(1):86. PubMed ID: 1905431
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.